Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +12.4%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (494)

clinicaltrialsPublishedShowing 151–200 of 1,112 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07796061	Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)(LIFT)	not yet recruiting	Phase 1	45	Children's National Research InstituteOTHER	0	Aug 31, 2026	clinicaltrials
NCT02142803	TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors	active not recruiting	Phase 1	50	National Cancer Institute (NCI)